Clinical Trial Update: Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

View source ↗

Summary

An observational study completed by Novo Nordisk describes conditions for administering a slow-acting insulin analogue with oral antidiabetic agents in Type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Slow-acting insulin analogue (insulin analogue, slow-acting)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED